Cargando…
Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step
Autores principales: | Billard, Marie-Noëlle, Bont, Louis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924581/ https://www.ncbi.nlm.nih.gov/pubmed/32986467 http://dx.doi.org/10.1164/rccm.202009-3431ED |
Ejemplares similares
-
Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019) -
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures
por: Billard, Marie‐Noëlle, et al.
Publicado: (2022) -
Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015) -
Attenuated Respiratory Syncytial Virus Vaccines in Asthmatic Children
por: Mcintosh, Kenneth, et al.
Publicado: (1974) -
Neutrophils in respiratory syncytial virus infection: A target for asthma prevention
por: Geerdink, Ruben J., et al.
Publicado: (2015)